BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8386905)

  • 1. Reversible cardiac dysfunction associated with foscarnet therapy for cytomegalovirus esophagitis in an AIDS patient.
    Brown DL; Sather S; Cheitlin MD
    Am Heart J; 1993 May; 125(5 Pt 1):1439-41. PubMed ID: 8386905
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
    Parente F; Bianchi Porro G
    Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ulcer in the urethral meatus and HIV infection].
    Len O; de Otero J; Ribera E; Ocaña I
    Enferm Infecc Microbiol Clin; 1995 Oct; 13(8):497-8. PubMed ID: 8555318
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis and treatment of esophagitis in AIDS.
    Mönkemüller KE; Wilcox CM
    Compr Ther; 2000; 26(3):163-8. PubMed ID: 10984820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actinomyces infection of a cytomegalovirus esophageal ulcer in two patients with acquired immunodeficiency syndrome.
    Poles MA; McMeeking AA; Scholes JV; Dieterich DT
    Am J Gastroenterol; 1994 Sep; 89(9):1569-72. PubMed ID: 8079942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Foscarnet and genital lesions].
    Miguélez M; Linares Feria M; Laynez P; Méndez M
    Med Clin (Barc); 1993 May; 100(18):717-8. PubMed ID: 8388069
    [No Abstract]   [Full Text] [Related]  

  • 7. Uvula and oesophageal ulcerations with foscarnet.
    Saint-Marc T; Fournier F; Touraine JL; Marneff E
    Lancet; 1992 Oct; 340(8825):970-1. PubMed ID: 1357364
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of gastrointestinal cytomegalovirus infection with twice-daily foscarnet: a pilot study of safety, efficacy, and pharmacokinetics in patients with AIDS.
    Dieterich DT; Poles MA; Lew EA; Martin-Munley S; Johnson J; Nix D; Faust MJ
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1226-30. PubMed ID: 9174175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foscarnet-induced hypercalcaemia in AIDS.
    Gayet S; Ville E; Durand JM; Mars ME; Morange S; Kaplanski G; Gallais H; Soubeyrand J
    AIDS; 1997 Jul; 11(8):1068-70. PubMed ID: 9223751
    [No Abstract]   [Full Text] [Related]  

  • 10. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
    Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
    Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penile ulceration with foscarnet therapy.
    Moyle G; Barton S; Gazzard BG
    AIDS; 1993 Jan; 7(1):140-1. PubMed ID: 8382924
    [No Abstract]   [Full Text] [Related]  

  • 12. Foscarnet treatment in various cytomegalovirus infections.
    Brockmeyer NH; Hengge UR; Mertins L; Malessa R; Steinmetz R; Gooss M
    Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):204-7. PubMed ID: 8388868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foscarnet decreases human immunodeficiency virus RNA.
    Kaiser L; Perrin L; Hirschel B; Furrer H; Von Overbeck J; Olmari M; Yerly S
    J Infect Dis; 1995 Jul; 172(1):225-7. PubMed ID: 7797916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction.
    Dieterich DT; Poles MA; Dicker M; Tepper R; Lew E
    Am J Gastroenterol; 1993 Apr; 88(4):542-8. PubMed ID: 8385880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal tolerance of combined treatment with foscarnet and indinavir.
    Guery B; Katlama C; Bochet M; Deray G
    Nephrol Dial Transplant; 1998 Mar; 13(3):815-6. PubMed ID: 9550685
    [No Abstract]   [Full Text] [Related]  

  • 16. Polyradiculopathy due to cytomegalovirus infection: report of a case in which an AIDS patient responded to foscarnet therapy.
    Domingo P; Puig M; Iranzo A; Lopez-Contreras J; Ris J
    Clin Infect Dis; 1994 Jun; 18(6):1019-21. PubMed ID: 8086536
    [No Abstract]   [Full Text] [Related]  

  • 17. A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS.
    Jacobson MA; Causey D; Polsky B; Hardy D; Chown M; Davis R; O'Donnell JJ; Kuppermann BD; Heinemann MH; Holland GN
    J Infect Dis; 1993 Aug; 168(2):444-8. PubMed ID: 8393058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrogenic diabetes insipidus associated with foscarnet--a case report.
    Conn J; Colman P; Brown G; Street A; Bate K
    J Antimicrob Chemother; 1996 Jun; 37(6):1179-81. PubMed ID: 8836823
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytomegalovirus infections in AIDS].
    Raffi F
    Rev Prat; 1995 Mar; 45(6):733-8. PubMed ID: 7754312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical aspects and therapy of infection with cytomegalovirus].
    Reusser P
    Internist (Berl); 1992 Sep; 33(9):593-6. PubMed ID: 1328108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.